Abstract
The current situation of hepatocellular carcinoma (HCC) management is challenging due to its high incidence, mortality, recurrence, and metastasis. Recent advances in gene genetic and expression regulation have unveiled the significant role of non-coding RNA (ncRNA) in various cancers. This led to the formulation of the competing endogenous RNA (ceRNA) hypothesis, which posits that both coding RNA and ncRNA, containing miRNA response elements (MRE), can share the same miRNA sequence. This results in a competitive network between ncRNAs, such as lncRNA and mRNA, allowing them to regulate each other. Extensive research has highlighted the crucial role of the ceRNA network in HCC development, impacting various cellular processes including proliferation, metastasis, cell death, angiogenesis, tumor microenvironment, organismal immunity, and chemotherapy resistance. Additionally, the ceRNA network, mediated by lncRNA or circRNA, offers potential in early diagnosis and prevention of HCC. Consequently, ceRNAs are emerging as therapeutic targets for HCC. The complexity of these gene networks aligns with the multi-target approach of traditional Chinese medicine (TCM), presenting a novel perspective for TCM in combating HCC. Research is beginning to show that TCM compounds and prescriptions can affect HCC progression through the ceRNA network, inhibiting proliferation and metastasis, and inducing apoptosis. Currently, the lncRNAs TUG1, NEAT1, and CCAT1, along with their associated ceRNA networks, are among the most promising ncRNAs for HCC research. However, this field is still in its infancy, necessitating advanced technology and extensive basic research to fully understand the ceRNA network mechanisms of TCM in HCC treatment.
Introduction
Hepatocellular carcinoma (HCC) remains a global health crisis, characterized by high mortality rates and frequent late-stage diagnoses. Traditional therapeutic approaches often struggle against the hallmarks of HCC, such as chemotherapy resistance and aggressive metastasis. While historical research focused primarily on protein-coding mRNAs, the advent of advanced transcriptomics has revealed that non-coding RNAs (ncRNAs)—including long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs)—constitute the vast majority of the human transcriptome. Understanding the interplay between these molecules is essential for developing next-generation diagnostics and systems-level therapies.
The ceRNA Hypothesis: A Molecular "Sponge" Network
The competing endogenous RNA (ceRNA) hypothesis provides a systems-biology framework for understanding gene regulation. At its core, the hypothesis suggests that different RNA molecules compete for a limited pool of microRNAs (miRNAs). These RNAs share miRNA response elements (MREs), allowing them to act as molecular "sponges."
In this network, when an ncRNA (like a lncRNA) "sponges" a specific miRNA, it prevents that miRNA from binding to its target mRNA. This effectively protects the mRNA from degradation, allowing it to be translated into protein. For example, the lncRNA TUG1 has been shown to sponge miR-1-3p, which in turn prevents the degradation of IGF1, thereby fueling tumor cell growth in HCC.
Clinical Significance: Diagnostics and Hallmarks of Cancer
The ceRNA network is deeply involved in various hallmarks of cancer, including proliferation, apoptosis, and the tumor microenvironment. Notably, research has expanded into "newer" cell death pathways like ferroptosis (iron-dependent cell death). For instance, the lncRNA NEAT1 can diminish MIOX repression, increasing the susceptibility of HCC cells to ferroptosis.
From a diagnostic perspective, ceRNA networks offer superior biomarkers compared to traditional single-protein markers. A diagnostic model combining NEAT1, TUG1, and AFP (alpha-fetoprotein) achieved a remarkable AUC of 0.981, with 100% sensitivity and 88.9% specificity. This significantly outperforms the use of AFP alone, which is the current clinical standard.
Traditional Chinese Medicine (TCM) and Multi-Target Therapy
The inherent complexity of ceRNA networks aligns uniquely with the "multi-component, multi-target" philosophy of Traditional Chinese Medicine (TCM). Because ceRNA networks involve multiple interacting nodes, they provide a modern molecular framework for understanding the systemic effects of herbal remedies.
Specific TCM compounds have already been mapped to these regulatory axes. For example, Aloin, derived from Aloe vera, inhibits HCC progression by modulating the circ0011385/miR-149-5p/WT1 axis. Similarly, compounds like Curcumin are being investigated for their ability to disrupt oncogenic ceRNA circuits and inhibit metastasis.
Future Directions
Despite the promise of ceRNA research, the field is in its early stages. Most current findings are derived from in vitro or in vivo animal models, and extensive clinical trials are required to validate these targets for human use. Furthermore, the complexity of TCM prescriptions makes identifying exact molecular targets challenging. Future work must integrate single-cell sequencing and advanced computational modeling to map the heterogeneity of these interactions across different patient populations and tumor stages.
Summary updated